Adaptive Biotechnologies Corporation
ADPT
$12.63
$0.3352.73%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -25.61M | -29.85M | -33.69M | -32.07M | -46.22M |
| Total Depreciation and Amortization | 4.50M | 4.73M | 4.45M | 4.59M | 5.00M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 13.99M | 12.78M | 13.70M | 13.44M | 21.09M |
| Change in Net Operating Assets | -5.31M | -16.14M | 3.05M | -13.03M | 2.83M |
| Cash from Operations | -12.43M | -28.48M | -12.49M | -27.07M | -17.30M |
| Capital Expenditure | -655.00K | -1.26M | -80.00K | -344.00K | -1.73M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 4.00M | 26.83M | 22.20M | 5.63M | 7.61M |
| Cash from Investing | 3.35M | 25.57M | 22.12M | 5.29M | 5.88M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 1.61M | 5.45M | 127.00K | 40.00K | 30.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 1.61M | 5.45M | 127.00K | 40.00K | 30.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -7.47M | 2.54M | 9.76M | -21.74M | -11.40M |